{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:59:18Z","timestamp":1781639958935,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007684","name":"Ministry of Education and Science of Ukraine","doi-asserted-by":"publisher","award":["BG-19F"],"award-info":[{"award-number":["BG-19F"]}],"id":[{"id":"10.13039\/501100007684","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01DK24009"],"award-info":[{"award-number":["01DK24009"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["R03TW009424"],"award-info":[{"award-number":["R03TW009424"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Streptomyces viridosporus<\/jats:italic>\n                    (formerly\n                    <jats:italic>ghanaensis<\/jats:italic>\n                    ) ATCC14672 is the best-studied producer of moenomycins, a family of phosphoglycolipid natural products directly inhibiting peptidoglycan glycosyltransferases. The uniqueness of moenomycins, in terms of structure and mode of action, and their extreme potency against several Gram-positive pathogens (including vancomycin- and methicillin-resistant cocci), are their advantages as a drug candidate. However, they are not orally bioavailable; in the bloodstream, moenomycins are characterized by an exceedingly long half-life. These shortcomings are thought to be caused by the long C25 lipid chain (moenocinol) of moenomycins. Here we report the generation and initial studies of two ATCC 14672 mutants to access a greater diversity of moenomycins around its lipid chain. The dO5 mutant cannot produce any moenomycins due to the deletion of the\n                    <jats:italic>moeO5<\/jats:italic>\n                    gene for the first step in moenomycin assembly. The M12 mutant of ATCC 14672 (knockout of the prenyltransferase gene\n                    <jats:italic>moeN5<\/jats:italic>\n                    ) accumulates moenomycins with a C15 lipid chain instead of moenocinol. We demonstrate and discuss the potential applications of the dO5 and M12 mutants for the discovery of novel moenomycins and their genetic determinants.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-43988-6","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T05:52:11Z","timestamp":1773121931000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetically engineered Streptomyces viridosporus ATCC 14672 strains for the discovery of novel moenomycins"],"prefix":"10.1038","volume":"16","author":[{"given":"Bohdan","family":"Ostash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Makitrynskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Fedchyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Luzhetskyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Fedorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"43988_CR1","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","unstructured":"GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050. Lancet 404, 1199\u20131226. https:\/\/doi.org\/10.1016\/S0140-6736(24)01867-1 (2024).","journal-title":"Lancet"},{"key":"43988_CR2","doi-asserted-by":"publisher","first-page":"100065","DOI":"10.1016\/j.bbadva.2022.100065","volume":"2","author":"B Ostash","year":"2022","unstructured":"Ostash, B., Makitrynskyy, R., Yushchuk, O. & Fedorenko, V. Structural diversity, bioactivity, and biosynthesis of phosphoglycolipid family antibiotics: recent advances. BBA Adv. 2, 100065. https:\/\/doi.org\/10.1016\/j.bbadva.2022.100065 (2022).","journal-title":"BBA Adv."},{"key":"43988_CR3","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1073\/pnas.09314921","volume":"100","author":"L Chen","year":"2003","unstructured":"Chen, L. et al. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate. Proc. Natl. Acad. Sci. USA. 100, 5658\u20135663. https:\/\/doi.org\/10.1073\/pnas.09314921 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"43988_CR4","doi-asserted-by":"publisher","first-page":"9771","DOI":"10.1016\/j.tet.2011.09.114","volume":"67","author":"C Gampe","year":"2011","unstructured":"Gampe, C., Tsukamoto, H., Wang, T., Walker, S. & Kahne, D. Modular synthesis of diphospholipid oligosaccharide fragments of the bacterial cell wall and their use to study the mechanism of moenomycin and other antibiotics. Tetrahedron 67, 9771\u20139778. https:\/\/doi.org\/10.1016\/j.tet.2011.09.114 (2011).","journal-title":"Tetrahedron"},{"key":"43988_CR5","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1039\/C001461N","volume":"27","author":"B Ostash","year":"2010","unstructured":"Ostash, B. & Walker, S. Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity. Nat. Prod. Rep. 27, 1594\u20131617. https:\/\/doi.org\/10.1039\/C001461N (2010).","journal-title":"Nat. Prod. Rep."},{"key":"43988_CR6","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1021\/ja065907x","volume":"128","author":"J Taylor","year":"2006","unstructured":"Taylor, J., Li, X., Oberth\u00fcr, M., Zhu, W. & Kahne, D. The total synthesis of moenomycin A. J. Am. Chem. Soc. 128, 15084\u201315085. https:\/\/doi.org\/10.1021\/ja065907x (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"43988_CR7","doi-asserted-by":"publisher","first-page":"14012","DOI":"10.1021\/ja065905c","volume":"128","author":"M Adachi","year":"2006","unstructured":"Adachi, M. et al. Degradation and reconstruction of moenomycin A and derivatives: dissecting the function of the isoprenoid chain. J. Am. Chem. Soc. 128, 14012\u201314013. https:\/\/doi.org\/10.1021\/ja065905c (2006).","journal-title":"J. Am. Chem. Soc."},{"key":"43988_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/cb100048q","volume":"5","author":"S Fuse","year":"2010","unstructured":"Fuse, S. et al. Functional and structural analysis of a key region of the cell wall inhibitor moenomycin. ACS Chem. Biol. 5, 701\u2013711. https:\/\/doi.org\/10.1021\/cb100048q (2010).","journal-title":"ACS Chem. Biol."},{"key":"43988_CR9","doi-asserted-by":"publisher","first-page":"8830","DOI":"10.1021\/bi901018q","volume":"48","author":"B Ostash","year":"2009","unstructured":"Ostash, B. et al. Complete characterization of the seventeen step moenomycin biosynthetic pathway. Biochemistry 48, 8830\u20138841. https:\/\/doi.org\/10.1021\/bi901018q (2009).","journal-title":"Biochemistry"},{"key":"43988_CR10","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1111\/mmi.12437","volume":"90","author":"B Ostash","year":"2013","unstructured":"Ostash, B., Campbell, J., Luzhetskyy, A. & Walker, S. MoeH5: a natural glycorandomizer from the moenomycin biosynthetic pathway. Mol. Microbiol. 90, 1324\u20131338. https:\/\/doi.org\/10.1111\/mmi.12437 (2013).","journal-title":"Mol. Microbiol."},{"key":"43988_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.chembiol.2007.01.008","volume":"14","author":"B Ostash","year":"2007","unstructured":"Ostash, B., Saghatelian, A. & Walker, S. A streamlined metabolic pathway for the biosynthesis of moenomycin A. Chem. Biol. 14, 257\u2013267. https:\/\/doi.org\/10.1016\/j.chembiol.2007.01.008 (2007).","journal-title":"Chem. Biol."},{"key":"43988_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12088-018-0761-x","volume":"59","author":"Y Kuzhyk","year":"2019","unstructured":"Kuzhyk, Y., Lopatniuk, M., Luzhetskyy, A., Fedorenko, V. & Ostash, B. Genome engineering approaches to improve nosokomycin A production by Streptomyces ghanaensis B38.3. Indian J. Microbiol. 59, 109\u2013111. https:\/\/doi.org\/10.1007\/s12088-018-0761-x (2019).","journal-title":"Indian J. Microbiol."},{"key":"43988_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1099\/mic.0.000747","volume":"165","author":"Y Sehin","year":"2019","unstructured":"Sehin, Y. et al. Gene ssfg_01967 (miaB) for tRNA modification influences morphogenesis and moenomycin biosynthesis in Streptomyces ghanaensis ATCC14672. Microbiology 165, 233\u2013245. https:\/\/doi.org\/10.1099\/mic.0.000747 (2019).","journal-title":"Microbiology"},{"key":"43988_CR14","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1002\/anie.201108002","volume":"51","author":"F Ren","year":"2012","unstructured":"Ren, F. et al. Insights into the mechanism of the antibiotic-synthesizing enzyme MoeO5 from crystal structures of different complexes. Angew Chem. Int. Ed. Engl. 51, 4157\u20134160. https:\/\/doi.org\/10.1002\/anie.201108002 (2012).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"43988_CR15","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1002\/anie.201511388","volume":"55","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Moenomycin biosynthesis: structure and mechanism of action of the prenyltransferase MoeN5. Angew Chem. Int. Ed. Engl. 55, 4716\u20134720. https:\/\/doi.org\/10.1002\/anie.201511388 (2016).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"43988_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.bbrc.2019.02.131","volume":"511","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Complex structures of MoeN5 with substrate analogues suggest sequential catalytic mechanism. Biochem. Biophys. Res. Commun. 511, 800\u2013805. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.131 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"43988_CR17","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1128\/aem.06054-11","volume":"78","author":"S Herrmann","year":"2012","unstructured":"Herrmann, S. et al. Site-specific recombination strategies for engineering actinomycete genomes. Appl. Environ. Microbiol. 78, 1804\u20131812. https:\/\/doi.org\/10.1128\/aem.06054-11 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"43988_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0065-2164(04)54004-2","volume":"54","author":"B Gust","year":"2004","unstructured":"Gust, B. et al. Lambda red-mediated genetic manipulation of antibiotic-producing Streptomyces. Adv. Appl. Microbiol. 54, 107\u2013128. https:\/\/doi.org\/10.1016\/s0065-2164(04)54004-2 (2004).","journal-title":"Adv. Appl. Microbiol."},{"key":"43988_CR19","doi-asserted-by":"publisher","first-page":"168018","DOI":"10.1016\/j.jmb.2023.168018","volume":"435","author":"N Oberg","year":"2023","unstructured":"Oberg, N., Zallot, R. & Gerlt, J. A. EFI-EST, EFI-GNT, and EFI-CGFP: Enzyme Function Initiative (EFI) Web Resource for Genomic Enzymology Tools. J. Mol. Biol. 435, 168018. https:\/\/doi.org\/10.1016\/j.jmb.2023.168018 (2023).","journal-title":"J. Mol. Biol."},{"key":"43988_CR20","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res."},{"key":"43988_CR21","doi-asserted-by":"publisher","first-page":"23005","DOI":"10.1002\/anie.202009611","volume":"59","author":"C Zhang","year":"2020","unstructured":"Zhang, C. & Seyedsayamdost, M. R. Discovery of a cryptic depsipeptide from Streptomyces ghanaensis via MALDI-MS-guided high-throughput elicitor screening. Angew Chem. Int. Ed. Engl. 59, 23005\u201323009. https:\/\/doi.org\/10.1002\/anie.202009611 (2020).","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"43988_CR22","doi-asserted-by":"publisher","first-page":"e202403985","DOI":"10.1002\/chem.202403985","volume":"31","author":"R Makitrynskyy","year":"2025","unstructured":"Makitrynskyy, R. et al. Olikomycin A \u2013 a novel calcium-dependent lipopeptide with antibiotic activity against multidrug-resistant bacteria. Chemistry 31, e202403985. https:\/\/doi.org\/10.1002\/chem.202403985 (2025).","journal-title":"Chemistry"},{"key":"43988_CR23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/nar\/gkz1220","volume":"48","author":"R Makitrynskyy","year":"2020","unstructured":"Makitrynskyy, R. et al. Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes. Nucleic Acids Res. 48, 1583\u20131598. https:\/\/doi.org\/10.1093\/nar\/gkz1220 (2020).","journal-title":"Nucleic Acids Res."},{"key":"43988_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1038\/s41564-017-0039-9","volume":"2","author":"N Tobias","year":"2017","unstructured":"Tobias, N. et al. Natural product diversity associated with the nematode symbionts Photorhabdus and Xenorhabdus. Nat. Microbiol. 2, 1676\u20131685. https:\/\/doi.org\/10.1038\/s41564-017-0039-9 (2017).","journal-title":"Nat. Microbiol."},{"key":"43988_CR25","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.jasms.2006.04.019","volume":"17","author":"M Zehl","year":"2006","unstructured":"Zehl, M., Pittenauer, E., Rizzi, A. & Allmaier, G. Characterization of moenomycin antibiotic complex by multistage MALDI-IT\/RTOF-MS and ESI-IT-MS. J. Am. Soc. Mass. Spectrom. 17, 1081\u20131090. https:\/\/doi.org\/10.1016\/j.jasms.2006.04.019 (2006).","journal-title":"J. Am. Soc. Mass. Spectrom."},{"issue":"D1","key":"43988_CR26","doi-asserted-by":"publisher","first-page":"D490","DOI":"10.1093\/nar\/gkaa812","volume":"49","author":"S Kautsar","year":"2021","unstructured":"Kautsar, S., Blin, K., Shaw, S., Weber, T. & Medema, M. H. BiG-FAM: the biosynthetic gene cluster families database. Nucleic Acids Res. 49 (D1), D490\u2013D497. https:\/\/doi.org\/10.1093\/nar\/gkaa812 (2021).","journal-title":"Nucleic Acids Res."},{"key":"43988_CR27","doi-asserted-by":"publisher","first-page":"giaa154","DOI":"10.1093\/gigascience\/giaa154","volume":"10","author":"S Kautsar","year":"2021","unstructured":"Kautsar, S., van der Hooft, J., de Ridder, D. & Medema, M. BiG-SLiCE: A highly scalable tool maps the diversity of 1.2 million biosynthetic gene clusters. Gigascience 10, giaa154. https:\/\/doi.org\/10.1093\/gigascience\/giaa154 (2021).","journal-title":"Gigascience"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43988-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43988-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:43:15Z","timestamp":1781638995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43988-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43988-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12851"}}